Association of Trypanolytic ApoL 1 Variants with Kidney Disease in African Americans

African Americans have higher rates of kidney disease than European Americans. Here, we show that, in African Americans, focal segmental glomerulosclerosis (FSGS) and hypertension-attributed end-stage kidney disease (H-ESKD) are associated with two independent sequence variants in the APOL1 gene on chromosome 22 {FSGS odds ratio = 10.5 [95% confidence interval (CI) 6.0 to 18.4]; H-ESKD odds ratio = 7.3 (95% CI 5.6 to 9.5)}. The two APOL1 variants are common in African chromosomes but absent from European chromosomes, and both reside within haplotypes that harbor signatures of positive selection. ApoL1 (apolipoprotein L-1) is a serum factor that lyses trypanosomes. In vitro assays revealed that only the kidney disease–associated ApoL1 variants lysed Trypanosoma brucei rhodesiense. We speculate that evolution of a critical survival factor in Africa may have contributed to the high rates of renal disease in African Americans.

[1]  J. Nedelman,et al.  Race, socioeconomic status, and the development of end-stage renal disease. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  Zhaohui S. Qin,et al.  A second generation human haplotype map of over 3.1 million SNPs , 2007, Nature.

[3]  Or Zuk,et al.  A Composite of Multiple Signals Distinguishes Causal Variants in Regions of Positive Selection , 2010, Science.

[4]  W. Gibson.  Will the real Trypanosoma b. gambiense please stand up. , 1986, Parasitology today.

[5]  J. Pritchard,et al.  A Map of Recent Positive Selection in the Human Genome , 2006, PLoS biology.

[6]  D. Vlahov,et al.  MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis , 2008, Nature Genetics.

[7]  L. Quintana-Murci,et al.  Natural selection has driven population differentiation in modern humans , 2008, Nature Genetics.

[8]  P. Simarro,et al.  Eliminating Human African Trypanosomiasis: Where Do We Stand and What Comes Next> , 2008, PLoS medicine.

[9]  C. Winkler,et al.  Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15 , 2010, Human molecular genetics.

[10]  Pardis C Sabeti,et al.  Positive Natural Selection in the Human Lineage , 2006, Science.

[11]  R. Brasseur,et al.  Apolipoprotein L-I Promotes Trypanosome Lysis by Forming Pores in Lysosomal Membranes , 2005, Science.

[12]  Pardis C Sabeti,et al.  Detecting recent positive selection in the human genome from haplotype structure , 2002, Nature.

[13]  B. Freedman,et al.  Genetic factors in end-stage renal disease. , 2005, Kidney international. Supplement.

[14]  D. Reich,et al.  MYH9 is associated with nondiabetic end-stage renal disease in African Americans , 2008, Nature Genetics.

[15]  T. Williams,et al.  Human red blood cell polymorphisms and malaria. , 2006, Current opinion in microbiology.

[16]  R. Brasseur,et al.  Apolipoprotein L-I is the trypanosome lytic factor of human serum , 2003, Nature.

[17]  W. Gibson.  Will the real Trypanosoma brucei rhodesiense please step forward? , 2002, Trends in parasitology.

[18]  Yongmei Liu,et al.  Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. , 2009, Kidney international.

[19]  L. Lins,et al.  C-Terminal Mutants of Apolipoprotein L-I Efficiently Kill Both Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense , 2009, PLoS pathogens.

[20]  A. Fujimoto,et al.  A Practical Genome Scan for Population-Specific Strong Selective Sweeps That Have Reached Fixation , 2007, PloS one.

[21]  L. Vanhamme,et al.  A VSG Expression Site–Associated Gene Confers Resistance to Human Serum in Trypanosoma rhodesiense , 1998, Cell.

[22]  C. Winkler,et al.  Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.